AEON Biopharma, Inc. Quarterly Unrecognized Tax Benefits in USD from Q4 2020 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of unrecognized tax benefits.
Summary
AEON Biopharma, Inc. quarterly Unrecognized Tax Benefits history and growth rate from Q4 2020 to Q4 2023.
  • AEON Biopharma, Inc. Unrecognized Tax Benefits for the quarter ending December 31, 2023 was $14.7M, a 32.6% increase year-over-year.
Unrecognized Tax Benefits, Quarterly (USD)
Unrecognized Tax Benefits, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $14.7M +$3.61M +32.6% Dec 31, 2023 10-K/A 2024-05-14
Q2 2023 $0 $0 Jun 30, 2023 10-Q 2023-07-21
Q1 2023 $0 $0 Mar 31, 2023 10-Q 2023-05-17
Q4 2022 $11.1M +$3.79M +52.1% Dec 31, 2022 10-K/A 2024-05-14
Q3 2022 $0 $0 Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $0 $0 Jun 30, 2022 10-Q 2022-08-12
Q1 2022 $0 $0 Mar 31, 2022 10-Q 2022-05-12
Q4 2021 $7.27M +$7.27M Dec 31, 2021 10-K/A 2024-05-14
Q3 2021 $0 Sep 30, 2021 10-Q/A 2022-03-03
Q2 2021 $0 Jun 30, 2021 10-Q/A 2022-03-03
Q1 2021 $0 Mar 31, 2021 10-Q/A 2022-03-03
Q4 2020 $0 Dec 31, 2020 10-K 2022-03-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.